Developer docs
API playgroundTry for free, no card

Search company profiles

Emmetros

Full company profile

uuid000l2fq

Namestring
Emmetros
Legal namestring
emmetros.com
Websiteurl
emmetros.com
Company typeenum
Private
Founded yearint
2014
Descriptiontext

Emmetros was a Waterloo, Canada-based information technology company founded in 2014 that built AI-powered patient engagement technology for healthcare providers, most notably the SparxConnect platform. The company targeted hospitals and health systems seeking to improve patient education, hospital discharge processes, and patient safety during recovery, with SparxConnect positioned as a domain-specialized AI solution for personalized patient engagement and care information delivery. The company's go-to-market was narrowly vertical, addressing a single primary customer segment (Healthcare Providers / Hospitals) and focused on specific pain points around discharge optimization and post-discharge patient safety.

Operationally, Emmetros remained a small private company with 11-50 employees and disclosed only a single early-stage funding event from the Accelerator Centre in 2016. Pricing, distribution channels, and named customers were not publicly disclosed, and the company's public web presence (emmetros.com) shows a "Launching Soon" landing page with no operational product information, suggesting a thin external commercial footprint. The single known executive is Alex Dlugokecki (Director, Software Development), reflecting an engineering-led, founder-stage team. In November 2025, Emmetros was acquired by FluidAI Medical, with FluidAI absorbing the SparxConnect assets into its Stream Inara AI-powered patient education platform, effectively ending Emmetros' independent operations.

Short descriptiontext

Emmetros was a Waterloo, Canada-based healthcare IT company that developed SparxConnect, an AI-powered patient education and engagement platform for hospitals, and was acquired by FluidAI Medical in November 2025.

Operating statusenum
Acquired
Ownership categoryenum
Headcount rangeband
11–50
akta.pro rankint
HeadquartersFergus, Canada
HQ citystring
Fergus
HQ countrystring
Canada
HQ regionstring
North America
Markets served

Serves global market

Keyword5 values
patient engagement software, healthcare AI platforms, patient education technology, hospital discharge solutions, care coordination software
SIC code1 code
  • Services-Prepackaged Software7372
Product category
Healthcare Patient Engagement Software
Social media profiles2 records
GTM typeB2B
B2B
Offering typeSoftware
Software
Brand1 record
1SparxConnect
Description

Patient engagement technology platform developed by Emmetros Limited

venturecapital.com
Core offering1 text field

Emmetros developed SparxConnect, an AI-powered patient engagement and education platform designed to support hospital discharge processes, care coordination, and patient safety during recovery. The platform delivers personalized patient engagement content to healthcare providers, with a focus on modernizing patient recovery through AI-driven education. The product was in pre-launch status as of late 2025, with the company website displaying "Launching Soon."

Differentiator
Functional benefit
Problem solved
Product overview1 text field

Emmetros Limited was a developer of patient engagement technology. The company's primary product was SparxConnect, a platform focused on patient education and engagement. The company was acquired by FluidAI Medical in November 2025 as part of FluidAI's strategy to enhance its AI-powered patient care offerings and modernize patient recovery technology.

Product and service1 record
1SparxConnect
CategoryPatient Engagement Software
Description

An AI-powered patient engagement and education platform designed to support personalized patient education, hospital discharge optimization, care coordination, and patient safety during recovery. Targeted at healthcare providers, particularly hospitals, to modernize patient recovery processes.

Partnership1 partner
1FluidAI Medical
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2025-11-26
Description

FluidAI Medical acquired the assets of Emmetros Limited as part of its strategy to expand and enhance its medical technology portfolio. The acquisition aims to strengthen FluidAI's AI-powered patient education platform, Stream Inara™, by incorporating Emmetros' SparxConnect technology to improve hospital discharges and patient safety during recovery.

Recent move4 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight2 records

Each record includes

Type, Description

Peers10 records
1PatientTrak
TypeEmerging player
Description

PatientTrak provides patient flow, engagement, and satisfaction tools for hospitals, partially overlapping Emmetros' patient engagement and recovery-monitoring capabilities.

2GetWellNetwork
TypeDirect peer
Description

GetWellNetwork provides an enterprise patient engagement platform used by hospitals for discharge education, care plans, and post-acute follow-up, directly overlapping Emmetros' SparxConnect use cases.

3CipherHealth
TypeDirect peer
Description

CipherHealth offers AI-driven patient outreach, discharge follow-up, and recovery monitoring solutions to hospitals, competing in the same patient safety and discharge optimization category as Emmetros.

4SeamlessMD
TypeDirect peer
Description

SeamlessMD delivers digital care journey platforms for surgery and recovery, including discharge instructions and remote patient monitoring, closely aligned with Emmetros' hospital discharge focus.

5Force Therapeutics
TypeDirect peer
Description

Force Therapeutics provides a digital care platform for musculoskeletal recovery with patient education and remote monitoring, comparable to Emmetros' AI-driven recovery and education offering.

6Conversa Health
TypeDirect peer
Description

Conversa Health offers an AI-powered conversational patient engagement platform for healthcare providers, overlapping Emmetros' AI patient education and discharge engagement use cases.

7Healthwise
TypeBroad incumbent
Description

Healthwise is an established patient education and engagement vendor serving health systems with broader content libraries, comparable to Emmetros' patient-education positioning.

8Krames (Staywell)
TypeBroad incumbent
Description

Krames delivers patient education, discharge instructions, and engagement content to hospitals at scale, overlapping the discharge-optimization segment where Emmetros operates.

9Twistle by Health Catalyst
TypeBroad incumbent
Description

Twistle, now part of Health Catalyst, automates patient engagement pathways including discharge and post-acute follow-up, comparable to Emmetros' workflow-driven patient communication approach.

10Wellbe
TypeEmerging player
Description

Wellbe offers guided patient experience and discharge solutions for hospitals and ambulatory care, sharing the discharge-and-recovery engagement niche with Emmetros.

Market position
Strengths3 records

Each record includes

Headline, Details, Source

Weaknesses4 records

Each record includes

Headline, Details, Source

Competitive moat2 records

Each record includes

Type, Details

Key risks5 records

Each record includes

Headline, Details, Source

Key highlights4 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Segment1 record

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature1 record

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds1 record

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors1 record

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Emmetros

Healthcare Patient Engagement Softwareemmetros.com

Emmetros was a Waterloo, Canada-based healthcare IT company that developed SparxConnect, an AI-powered patient education and engagement platform for hospitals, and was acquired by FluidAI Medical in November 2025.

What Emmetros does

Emmetros was a Waterloo, Canada-based information technology company founded in 2014 that built AI-powered patient engagement technology for healthcare providers, most notably the SparxConnect platform. The company targeted hospitals and health systems seeking to improve patient education, hospital discharge processes, and patient safety during recovery, with SparxConnect positioned as a domain-specialized AI solution for personalized patient engagement and care information delivery. The company's go-to-market was narrowly vertical, addressing a single primary customer segment (Healthcare Providers / Hospitals) and focused on specific pain points around discharge optimization and post-discharge patient safety.

Operationally, Emmetros remained a small private company with 11-50 employees and disclosed only a single early-stage funding event from the Accelerator Centre in 2016. Pricing, distribution channels, and named customers were not publicly disclosed, and the company's public web presence (emmetros.com) shows a "Launching Soon" landing page with no operational product information, suggesting a thin external commercial footprint. The single known executive is Alex Dlugokecki (Director, Software Development), reflecting an engineering-led, founder-stage team. In November 2025, Emmetros was acquired by FluidAI Medical, with FluidAI absorbing the SparxConnect assets into its Stream Inara AI-powered patient education platform, effectively ending Emmetros' independent operations.

Emmetros firmographics

Firmographics
Name
Emmetros
Legal name
emmetros.com
Website
https://emmetros.com
Company type
Private
Founded year
2014
Operating status
Acquired
Headcount range
11–50 employees
Short description
Emmetros was a Waterloo, Canada-based healthcare IT company that developed SparxConnect, an AI-powered patient education and engagement platform for hospitals, and was acquired by FluidAI Medical in November 2025.
Ownership category
akta.pro rank

Where Emmetros is headquartered

Location

Headquarters

HQ city
Fergus
HQ country
Canada
HQ region
North America

Markets served

Emmetros business model

Business model
GTM type
B2B
Offering type
Software

Emmetros product offering

Product offering

Core offering

Emmetros developed SparxConnect, an AI-powered patient engagement and education platform designed to support hospital discharge processes, care coordination, and patient safety during recovery. The platform delivers personalized patient engagement content to healthcare providers, with a focus on modernizing patient recovery through AI-driven education. The product was in pre-launch status as of late 2025, with the company website displaying "Launching Soon."

Product overview

Emmetros Limited was a developer of patient engagement technology. The company's primary product was SparxConnect, a platform focused on patient education and engagement. The company was acquired by FluidAI Medical in November 2025 as part of FluidAI's strategy to enhance its AI-powered patient care offerings and modernize patient recovery technology.

Differentiator

Problem solved

Functional benefit

Brands

  • SparxConnect: Patient engagement technology platform developed by Emmetros Limited

Products and services

  • SparxConnect An AI-powered patient engagement and education platform designed to support personalized patient education, hospital discharge optimization, care coordination, and patient safety during recovery. Targeted at healthcare providers, particularly hospitals, to modernize patient recovery processes.

Companies that use Emmetros

Customer profile

Segments1 record

Emmetros technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature1 record

Emmetros partnerships and signals

Strategic signal

Partnerships

One partnership is on record.

  • FluidAI MedicalcoreStrategic or Co-development Partner · 26 November 2025FluidAI Medical acquired the assets of Emmetros Limited as part of its strategy to expand and enhance its medical technology portfolio. The acquisition aims to strengthen FluidAI's AI-powered patient education platform, Stream Inara™, by incorporating Emmetros' SparxConnect technology to improve hospital discharges and patient safety during recovery.

Recent moves4 records

Expansion highlights2 records

Emmetros competitors and assessment

Company assessment

Emerging players

  • PatientTrak: PatientTrak provides patient flow, engagement, and satisfaction tools for hospitals, partially overlapping Emmetros' patient engagement and recovery-monitoring capabilities.
  • Wellbe: Wellbe offers guided patient experience and discharge solutions for hospitals and ambulatory care, sharing the discharge-and-recovery engagement niche with Emmetros.

Direct peers

  • GetWellNetwork: GetWellNetwork provides an enterprise patient engagement platform used by hospitals for discharge education, care plans, and post-acute follow-up, directly overlapping Emmetros' SparxConnect use cases.
  • CipherHealth: CipherHealth offers AI-driven patient outreach, discharge follow-up, and recovery monitoring solutions to hospitals, competing in the same patient safety and discharge optimization category as Emmetros.
  • SeamlessMD: SeamlessMD delivers digital care journey platforms for surgery and recovery, including discharge instructions and remote patient monitoring, closely aligned with Emmetros' hospital discharge focus.
  • Force Therapeutics: Force Therapeutics provides a digital care platform for musculoskeletal recovery with patient education and remote monitoring, comparable to Emmetros' AI-driven recovery and education offering.
  • Conversa Health: Conversa Health offers an AI-powered conversational patient engagement platform for healthcare providers, overlapping Emmetros' AI patient education and discharge engagement use cases.

Broad incumbents

  • Healthwise: Healthwise is an established patient education and engagement vendor serving health systems with broader content libraries, comparable to Emmetros' patient-education positioning.
  • Krames (Staywell): Krames delivers patient education, discharge instructions, and engagement content to hospitals at scale, overlapping the discharge-optimization segment where Emmetros operates.
  • Twistle by Health Catalyst: Twistle, now part of Health Catalyst, automates patient engagement pathways including discharge and post-acute follow-up, comparable to Emmetros' workflow-driven patient communication approach.

Market position

Strengths3 records

Weaknesses4 records

Competitive moat2 records

Key risks5 records

Key highlights4 records

Customer concentration

Emmetros social profiles

Digital presence

Emmetros financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Emmetros leadership team

Management profile

Number of profiles

Emmetros funding detail

Funding detail

Funding overview

Funding rounds1 record

Investors1 record

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Emmetros M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Emmetros

What does Emmetros do?

Emmetros developed SparxConnect, an AI-powered patient engagement and education platform designed to support hospital discharge processes, care coordination, and patient safety during recovery. The platform delivers personalized patient engagement content to healthcare providers, with a focus on modernizing patient recovery through AI-driven education. The product was in pre-launch status as of late 2025, with the company website displaying "Launching Soon."

Is Emmetros a public or private company?

Emmetros is a private company. It is classified as corporate owned and is currently acquired.

When was Emmetros founded?

Emmetros was founded in 2014. It employs 11 to 50 people.

Where is Emmetros based?

Emmetros is headquartered in Fergus, Canada, in the North America region.

Who are Emmetros's main competitors?

Emerging players on record are PatientTrak and Wellbe. Direct peers are GetWellNetwork, CipherHealth, SeamlessMD, Force Therapeutics and Conversa Health. Broad incumbents are Healthwise, Krames (Staywell) and Twistle by Health Catalyst.

Does Emmetros have an API?

No public API is recorded for Emmetros.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
Startup ResearcherFluidAI acquires Emmetros to modernize patient recoveryFluidAI Medical has acquired Emmetros Limited to integrate its SparxConnect patient engagement platform into FluidAI’s Stream Inara system. The deal aims to modernize post-operative care by combining real-time monitoring with tailored educational content, enabling earlier hospital discharges while maintaining patient safety. Financial terms were not disclosed, marking this as FluidAI's second acquisition following its 2022 purchase of Medsix intellectual property.BetaKitFluidAI enters acquisition deal with Emmetros as it pushes to modernize patient recovery with AIHealthtech company FluidAI Medical has entered an acquisition deal to purchase the assets of Emmetros Limited, a firm specializing in patient engagement platforms. This strategic move aims to integrate Emmetros' SparxConnect technology with FluidAI's Stream Inara platform to enhance post-surgical monitoring and accelerate patient discharge. The transaction represents part of FluidAI's broader growth strategy following recent FDA approvals and funding rounds.YahooFluidAI acquires Emmetros to expand patient engagement platformCanada-based FluidAI Medical has acquired Emmetros, a developer of the SparxConnect platform, to expand its AI-powered patient engagement suite, Stream Inara. This transaction marks FluidAI's second acquisition following Medsix and aims to integrate Emmetros' technology to enhance post-discharge patient support and education. The integration is designed to improve care adherence, facilitate earlier hospital discharge, and optimize bed utilization for surgical patients.PR NewswireFluidAI Medical announces an acquisition deal with Emmetros LimitedFluidAI Medical announced the acquisition of Emmetros Limited, a developer of the SparxConnect patient engagement platform. This transaction integrates Emmetros' technology into FluidAI's Stream Inara™ platform to enhance post-discharge patient education and support earlier hospital discharge. The deal marks FluidAI's second acquisition, reinforcing its strategy to expand its surgical care product portfolio.MaadvisorLatest Market NewsFluidAI Medical announced its acquisition of Emmetros Limited, a company focused on patient engagement, enhancing its Stream Inara™ platform for patient education and engagement. This marks FluidAI's second acquisition as part of its growth strategy to improve surgical care and facilitate early patient discharge. The integration aims to monitor patients post-discharge and ensure they adhere to care plans for better recovery outcomes.